Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria-Reference-Cited by-同舟云学术

Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria

Published:2012-10 Issue:2 Volume:47 Page:217-221
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Piccirillo Nicola,Vacca Michele,Lanti Alessandro,Ipsevich Francesco,Maresca Maddalena,Fiorelli Elena,Bianchi Maria,Adorno Gaspare,Pierelli Luca,Majolino Ignazio,Leone Giuseppe,Zini Gina

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. In and out of the niche: perspectives in mobilization of hematopoietic stem cells;Mohty;Exp Hematol,2011

2. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients;Schmitz;Lancet,1996

3. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin’s and non-Hodgkin’s lymphoma;Smith;J Clin Oncol,1997

4. Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield;Duong;J Clin Apher,2011

5. Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost;Boeve;Bone Marrow Transplant,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of diabetes mellitus on hematopoietic stem cell mobilization, a-single center cohort study;Transfusion and Apheresis Science;2023-12

2. Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments;Annals of Hematology;2023-03-22

3. Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients;Transfusion Medicine and Hemotherapy;2022-09-05

4. Threshold for optimal administration of plerixafor in autologous peripheral blood stem cell collections through CD34 + cell monitoring based on the experience from two Japanese university hospitals;Therapeutic Apheresis and Dialysis;2021-01-07

5. Impact of CD34+ pre-counting and plerixafor on autologous peripheral blood stem cell collection in Japanese university hospitals in eight years;Transfusion and Apheresis Science;2019-12